Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis. | J Neurol | 2022 | 34191081 | PubTator, text mining | PubMed |
| The role of RNA editing enzyme ADAR1 in human disease. | Wiley Interdiscip Rev RNA | 2022 | 34105255 | PubTator, text mining | PubMed |
| DEBKS: A Tool to Detect Differentially Expressed Circular RNAs. | Genomics Proteomics Bioinformatics | 2022 | 33631429 | PubTator, text mining | PubMed |
| Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications. | Front Genet | 2021 | 35154242 | PubTator, text mining | PubMed |
| The Non-N6-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma. | Front Immunol | 2021 | 35154083 | PubTator, text mining | PubMed |
| Genome-wide expression changes mediated by A-to-I RNA editing correlate with hepatic oncogenesis. | Transl Cancer Res | 2021 | 35116583 | PubTator, text mining | PubMed |
| Organ on a Chip: A Novel in vitro Biomimetic Strategy in Amyotrophic Lateral Sclerosis (ALS) Modeling. | Front Neurol | 2021 | 35111126 | PubTator, text mining | PubMed |
| The Role of Circular RNAs in the Drug Resistance of Cancers. | Front Oncol | 2021 | 35070998 | PubTator, text mining | PubMed |
| Gene-Based Therapeutics for Inherited Retinal Diseases. | Front Genet | 2021 | 35069693 | PubTator, text mining | PubMed |
| Detection of A-to-I RNA Editing in SARS-COV-2. | Genes (Basel) | 2021 | 35052382 | PubTator, text mining | PubMed |
| Differential Analysis of A-to-I mRNA Edited Sites in Parkinson's Disease. | Genes (Basel) | 2021 | 35052353 | PubTator, text mining | PubMed |
| Potential biomarkers and signaling pathways associated with the pathogenesis of primary salivary gland carcinoma: a bioinformatics study. | Genomics Inform | 2021 | 35012286 | PubTator, text mining | PubMed |
| Downregulated ADARB1 Facilitates Cell Proliferation, Invasion and has Effect on the Immune Regulation in Ovarian Cancer. | Front Bioeng Biotechnol | 2021 | 35004651 | PubTator, text mining | PubMed |
| Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary Study. | Front Oncol | 2021 | 35004305 | PubTator, text mining | PubMed |
| Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis. | Dis Markers | 2021 | 35003395 | PubTator, text mining | PubMed |
| MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets. | Biomedicines | 2021 | 34944633 | PubTator, text mining | PubMed |
| Double-Stranded RNA Structural Elements Holding the Key to Translational Regulation in Cancer: The Case of Editing in RNA-Binding Motif Protein 8A. | Cells | 2021 | 34944051 | PubTator, text mining | PubMed |
| CRISPR-Based Approaches for the High-Throughput Characterization of Long Non-Coding RNAs. | Noncoding RNA | 2021 | 34940760 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma. | Front Pharmacol | 2021 | 34899345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=27